Abstract

Paragangliomas (glomus tumours) are benign, hypervascular tumours which in general are treated by surgical excision. The indication for treatment of these often slow-growing tumours needs additional criteria for predicting tumour progressiveness. For this reason the nuclear DNA content of 99 paragangliomas, 65 of them originating from patients with a positive family history, was analysed by flow cytometry. Unequivocal evidence of DNA aneuploidy was found in 37% of these clinically and histologically benign tumours, the average duration of follow up amounting to at least 10 years. The DNA index of the aneuploid tumours ranged from 0.90 to 2.03. No correlation was found between DNA ploidy and familiality or between DNA content and clinical criteria indicative of tumour progression, which means that DNA ploidy of these tumours cannot serve as a predictor for an expected growth pattern or familiality. DNA aneuploidy in hereditary and sporadic paragangliomas is not clinically related to malignancy, but indicates that these tumours are true neoplasias cytogenetically.

Highlights

  • The aim of the present study was to find out whether DNA aneuploidy could be detected in paragangliomas as support for a neoplastic origin and, if so, whether this DNA aneuploidy is associated with the clinical extension of the tumour and can be used as a predictor of the growth rate

  • The results indicate that DNA aneuploidy occurs relatively frequently in both familial and sporadic paragangliomas, but no correlations with clinical extension were found

  • These 108 patients accounted for a total of 173 paragangliomas, i.e., 50 glomus jugulotympanic tumours (GJTT), 32 vagal body tumours (VBT), and 91 carotid body tumours (CBT)

Read more

Summary

Objectives

The aim of the present study was to find out whether DNA aneuploidy could be detected in paragangliomas as support for a neoplastic origin and, if so, whether this DNA aneuploidy is associated with the clinical extension of the tumour and can be used as a predictor of the growth rate

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.